Bin d in g of Im id a zole-Der ived Nu cleosid es
to a CG Ba se P a ir
Maria G. M. Purwanto and Klaus Weisz*
Institut fu¨r Chemie und Biochemie,
Ernst-Moritz-Arndt-Universita¨t Greifswald,
Soldmannstrasse 16, D-17489 Greifswald, Germany
weisz@uni-greifswald.de
Received October 30, 2003
F IGURE 1. Hydrogen bond donor and acceptor sites of a CG
base pair and binding of a potential ligand with a complemen-
tary acceptor (A)-donor (D) motif; R ) O-protected ribose
sugar.
Abstr a ct: Novel imidazole nucleosides with substituents
of different flexibility were studied for their binding to a CG
Watson-Crick base pair by 1H NMR spectroscopy in an
aprotic solvent. Thermodynamic data as determined by
titration experiments at different temperatures reveal the
influence of the substituent on the enthalpy and entropy of
complex formation and thus on the strength of binding.
SCHEME 1. Syn th esis of 2 a n d 3
DNA triplex formation through Hoogsteen hydrogen
bonds between third-strand bases and the bases of the
duplex target is mostly limited to homopurine sequences.
However, excluding the effective recognition of pyrimi-
dine interruptions within a purine tract of the duplex
generally results in triple helices of low stability, thus
restricting potential applications. To overcome these
limitations, various nucleobase analogues have been
designed in the past as potential ligands for any given
base pair, but the reliable prediction of their interactions
within a triple helix has not yet been achieved.1,2 Re-
cently, we have reported the specific binding of a novel
urocanamide derived nucleoside 1 toward a CG Watson-
Crick base pair at its major groove side in an organic
solvent.3 Based on these results, we now describe binding
studies involving different structural variants 1-4.
All the nucleobases are expected to facilitate the
formation of two hydrogen bonds to a CG base pair, i.e.,
to NH2 of cytosine and the O6 carbonyl oxygen of guanine
(see Figure 1). To understand the effect of conformational
flexibility on base triple formation, nucleobases 3 and 4
were designed with increased and decreased side chain
flexibility, whereas 2 was additionally dedicated to study
the effect of an N-propyl substituent at the amide
function.
As was described for nucleoside 13, 2 was synthesized
starting with trans-urocanic acid, which after activation
using N-hydroxysuccinimide (NHS) and N-(3-dimethyl-
aminopropyl)-N′-ethylcarbodiimide hydrochloride (DCI)
reacted with propylamine to afford the corresponding
N-propylurocanamide (Scheme 1). This was glycosylated
to the O-protected nucleoside with 1-O-acetyl-2,3,5-tri-
O-benzoyl-â-D-ribofuranose under Vorbru¨ggen conditions.
Compound 1 was smoothly converted to 3 by a Pd-
mediated reduction of the double bond which did not
affect the sugar or the imidazole moiety. Compound 4
was synthesized based on the Bredereck imidazole syn-
thesis4 recently also employed by Griffin et al.5 This
procedure affords 2-unsubstituted imidazoles from an
R-hydroxy or an R-halogenated ketone (in this case
ω-bromo-m-nitroacetophenone) by using formamide as a
* Corresponding author.
(1) (a) Huang, C.-Y.; Miller, P. S. J . Am. Chem. Soc. 1993, 115,
10456-10457. (b) Sasaki, S.; Nakashima, S.; Nagatsugi, F.; Tanaka,
Y.; Hisatome, M.; Maeda, M. Tetrahedron Lett. 1995, 36, 9521-9524.
(c) Zimmerman, S. C.; Schmitt, P. J . Am. Chem. Soc. 1995, 117, 10769-
10770. (d) Lehmann, T. E.; Greenberg, W. A.; Liberles, D. A.; Wada,
C. K.; Dervan, P. B. Helv. Chim. Acta 1997, 80, 2002-2022. (e) Lecubin,
F.; Benhida, R.; Fourrey, J .-L.; Sun, J .-S. Tetrahedron Lett. 1999, 40,
8085-8088. (f) Lengeler, D.; Weisz, K. Tetrahedron Lett. 2001, 42,
1479-1481. (g) Guianvarc’h, D.; Benhida, R.; Fourrey, J .-L.; Maurisse,
R.; Sun, J .-S. J . Chem. Soc., Chem. Commun. 2001, 1814-1815.
(2) For reviews, see: (a) Doronina, S. O.; Behr, J .-P. Chem. Soc. Rev.
1997, 63-71. (b) Gowers, D. M.; Fox, K. R. Nucleic Acids Res. 1999,
27, 1569-1577. (c) Purwanto, M. G. M.; Weisz, K. Curr. Org. Chem.
2003, 7, 427-446.
(3) Purwanto, M. G. M.; Lengeler, D.; Weisz, K. Tetrahedron Lett.
2002, 43, 61-64.
10.1021/jo035597q CCC: $27.50 © 2004 American Chemical Society
Published on Web 12/05/2003
J . Org. Chem. 2004, 69, 195-197
195